These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2482710)

  • 21. Cardiovascular and electrophysiological analysis of a selective vasodilatory prostacyclin analogue, 5-nitro-PGI1.
    Kecskeméti V; Stadler I; Körmöczy P
    Biomed Biochim Acta; 1984; 43(8-9):S287-90. PubMed ID: 6440542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
    Mardla V; Kobzar G; Samel N
    Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
    J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients.
    Vicari AM; Macagni A; Pozza G
    Horm Metab Res; 1989 Nov; 21(11):616-8. PubMed ID: 2480323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
    Szekeres L; Krassói I; Pataricza J; Udvary E
    Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo antiaggregatory action of platelet-activating factor in beagle dogs: role for prostacyclin.
    Hermán F; Magyar K; Filep JG
    Thromb Haemost; 1991 Mar; 65(3):296-9. PubMed ID: 2048053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effect of iloprost on early pulmonary function after lung preservation with modified eurocollins solution.
    Klepetko W; Müller MR; Khünl-Brady G; Wisser W; Windisch A; Eckersberger F; Wolner E
    Thorac Cardiovasc Surg; 1989 Jun; 37(3):174-9. PubMed ID: 2474870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
    Merritt JE; Brown AM; Bund S; Cooper DG; Egan JW; Hallam TJ; Heagerty AM; Hickey DM; Kaumann AJ; Keen M
    Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
    Ubatuba FB; Moncada S; Vane JR
    Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man.
    Cowley AJ; Heptinstall S; Hampton JR
    Thromb Haemost; 1985 Feb; 53(1):90-4. PubMed ID: 2581332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of platelet aggregation by the filtration pressure method (author's transl)].
    Matsubara I
    Nihon Yakurigaku Zasshi; 1981 Sep; 78(3):173-84. PubMed ID: 7035311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iloprost binding and inhibition of aggregation in platelet rich plasma. Differences between normal and type IIa hypercholesterolemic subjects.
    Oliva DW; Maderna P; Accomazzo MR; Nicosia S; Tremoli E
    Biochem Pharmacol; 1989 Jan; 38(1):39-45. PubMed ID: 2462881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation.
    Sim AK; McCraw AP; Cleland ME; Nishio S; Umetsu T
    Arzneimittelforschung; 1985; 35(12):1816-8. PubMed ID: 3913423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship (SAR) among prostacyclin (PGI2) analogues.
    Kovács G; Székely I; Stadler I; Körmöczy P
    Acta Physiol Hung; 1984; 64(3-4):225-30. PubMed ID: 6397963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique.
    Czer GT; Moser KM
    J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiaggregatory efficacy and its time-course after application of acetylsalicylic acid, prostacyclin and nafazatrom in vivo.
    Herrmann KS
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):150-8. PubMed ID: 6393886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
    Jaschonek K; Faul C; Daiss W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
    Weithmann KU; Just M; Schlotte V; Seiffge D
    Vasa; 1989; 18(4):273-6. PubMed ID: 2514520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.